Benefits of Disease-Modifying Therapy in MS Patients
For a study, the researchers sought to forecast the conditional average treatment effect (CATE) for people on anti-CD20 monoclonal antibodies and laquinimod for a study. For this, researchers used a multitask multilayer...
Read More